Health and Healthcare

Teva : TEVA

All Teva Articles

450 Articles

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 28, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Bunge, Cheniere Energy, FedEx, Kinder Morgan, Micron Technology, Monster…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 20, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan,…

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 11, 2019 at 11:50 AM EDT

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

Even if a lot of this 10-year bull market was simply playing catch-up from the bottom, it still seems pretty…

Jon C. Ogg | Mar 6, 2019 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included CSX, Intelsat, Kohl's, NIO, Rio Tinto, Teva Pharmaceutical, TripAdvisor…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 14, 2019 at 8:58 AM EST

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

The top analyst upgrades, downgrades and initiations seen on Thursday included CenturyLink, Chimera Investment, Comerica, Dish Networks, Exxon Mobil, NetApp,…

Chris Lange | Feb 13, 2019 at 9:15 AM EST

What Held Back Teva in Q4

Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 10, 2019 at 9:55 AM EST

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

24/7 Wall St. has reviewed Coca-Cola, Deere and some of the other key companies reporting this coming week.

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 3 4 5 6 7 … 30

Teva : TEVA

All Teva Articles

Big Pharma Scares Off Short Sellers

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More

Major Pharma Sees a Few Wild Swings in Short Interest

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Big Pharma Short Interest Backs Off, With One Huge Exception

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Major Pharma Sees Tremendous Rise in Short Interest

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

What Held Back Teva in Q4

Major Pharma Scares Off Short Sellers

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

Short Interest Spikes in a Couple Major Pharma Stocks

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

Analyst: Forget the Chip Cycle, Because AI Demand Has Permanently Rewired Semiconductor Pricing

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

Analyst: Forget the Chip Cycle, Because AI Demand Has Permanently Rewired Semiconductor Pricing

Teva : TEVA

All Teva Articles

Big Pharma Scares Off Short Sellers

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More

Major Pharma Sees a Few Wild Swings in Short Interest

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Big Pharma Short Interest Backs Off, With One Huge Exception

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Major Pharma Sees Tremendous Rise in Short Interest

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

What Held Back Teva in Q4

Major Pharma Scares Off Short Sellers

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

Short Interest Spikes in a Couple Major Pharma Stocks

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

Analyst: Forget the Chip Cycle, Because AI Demand Has Permanently Rewired Semiconductor Pricing

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Featured Reads

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest